Why this matters
The Most Under-Funded Crisis in American Health.
9 of 10 leading causes of U.S. death are diseases of aging
<1% of global biotech investment targets the biology of aging itself
<$20M in annual U.S. funding for aging biology advocacy — less than any single major disease group
0 FDA-approved therapies target biological aging